Style | Citing Format |
---|---|
MLA | Eskandari A, et al.. "Melatonin a Promising Candidate for Dna Double-Stranded Breaks Reduction in Patients Undergoing Abdomen-Pelvis Computed Tomography Examinations." Anti-Cancer Agents in Medicinal Chemistry, vol. 20, no. 7, 2020, pp. 859-864. |
APA | Eskandari A, Mahmoudzadeh A, Shirazi A, Esmaely F, Carnovale C, Cheki M (2020). Melatonin a Promising Candidate for Dna Double-Stranded Breaks Reduction in Patients Undergoing Abdomen-Pelvis Computed Tomography Examinations. Anti-Cancer Agents in Medicinal Chemistry, 20(7), 859-864. |
Chicago | Eskandari A, Mahmoudzadeh A, Shirazi A, Esmaely F, Carnovale C, Cheki M. "Melatonin a Promising Candidate for Dna Double-Stranded Breaks Reduction in Patients Undergoing Abdomen-Pelvis Computed Tomography Examinations." Anti-Cancer Agents in Medicinal Chemistry 20, no. 7 (2020): 859-864. |
Harvard | Eskandari A et al. (2020) 'Melatonin a Promising Candidate for Dna Double-Stranded Breaks Reduction in Patients Undergoing Abdomen-Pelvis Computed Tomography Examinations', Anti-Cancer Agents in Medicinal Chemistry, 20(7), pp. 859-864. |
Vancouver | Eskandari A, Mahmoudzadeh A, Shirazi A, Esmaely F, Carnovale C, Cheki M. Melatonin a Promising Candidate for Dna Double-Stranded Breaks Reduction in Patients Undergoing Abdomen-Pelvis Computed Tomography Examinations. Anti-Cancer Agents in Medicinal Chemistry. 2020;20(7):859-864. |
BibTex | @article{ author = {Eskandari A and Mahmoudzadeh A and Shirazi A and Esmaely F and Carnovale C and Cheki M}, title = {Melatonin a Promising Candidate for Dna Double-Stranded Breaks Reduction in Patients Undergoing Abdomen-Pelvis Computed Tomography Examinations}, journal = {Anti-Cancer Agents in Medicinal Chemistry}, volume = {20}, number = {7}, pages = {859-864}, year = {2020} } |
RIS | TY - JOUR AU - Eskandari A AU - Mahmoudzadeh A AU - Shirazi A AU - Esmaely F AU - Carnovale C AU - Cheki M TI - Melatonin a Promising Candidate for Dna Double-Stranded Breaks Reduction in Patients Undergoing Abdomen-Pelvis Computed Tomography Examinations JO - Anti-Cancer Agents in Medicinal Chemistry VL - 20 IS - 7 SP - 859 EP - 864 PY - 2020 ER - |